Chimeric Antigen Receptor T Cells in Multiple Myeloma

被引：1
|
作者：
Shah, Parth [1 ,2 ,4 ]
Sperling, Adam S. [2 ,3 ]
机构：
[1] Dartmouth Canc Ctr, Dept Hematol, 1 Med Ctr Dr, Lebanon, NH 03750 USA
[2] Dana Farber Canc Inst, Med Oncol, 450 Brookline Ave, Boston, MA 02115 USA
[3] Brigham & Womens Hosp, Div Hematol, 75 Francis St, Boston, MA 02115 USA
[4] 1 Med Ctr Dr, Lebanon, NH 03750 USA
来源：
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | 2023年 / 37卷 / 06期
关键词：
Multiple myeloma; CAR-T; BCMA; GPRC5D; BiTEs; THERAPY; BCMA; MALIGNANCIES; MATURATION; ANTIBODY; COMBINATION; TRANSPLANT; EXPRESSION; PHASE-1; FUSION;
D O I：
10.1016/j.hoc.2023.05.008
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：1089 / 1105
页数：17
相关论文
共 50 条
  • [31] Chimeric Antigen Receptor (CAR) therapy for multiple myeloma
    Atanackovic, Djordje
    Radhakrishnan, Sabarinath V.
    Bhardwaj, Neelam
    Luetkens, Tim
    BRITISH JOURNAL OF HAEMATOLOGY, 2016, 172 (05) : 685 - 698
  • [32] Chimeric Antigen Receptor T Cells: Immunotherapy for the Treatment of Leukemia, Lymphoma, and Myeloma
    Rodriguez Gil de Montes, Angibelle Lizmar
    Spencer, Lilian Maritza
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (11) : 1261 - 1269
  • [33] Chimeric antigen receptor T cells
    Bories, Pierre
    Ysebaert, Loic
    BULLETIN DU CANCER, 2021, 108 (10) : S55 - S64
  • [34] T cells expressing an anti-B-cell maturation antigen chimeric antigen receptor cause remissions of multiple myeloma
    Ali, Syed Abbas
    Shi, Victoria
    Maric, Irina
    Wang, Michael
    Stroncek, David F.
    Rose, Jeremy J.
    Brudno, Jennifer N.
    Stetler-Stevenson, Maryalice
    Feldman, Steven A.
    Hansen, Brenna G.
    Fellowes, Vicki S.
    Hakim, Frances T.
    Gress, Ronald E.
    Kochenderfer, James N.
    BLOOD, 2016, 128 (13) : 1688 - 1700
  • [35] γ-Secretase inhibition increases efficacy of BCMA-specific chimeric antigen receptor T cells in multiple myeloma
    Pont, Margot J.
    Hill, Tyler
    Cole, Gabriel O.
    Abbott, Joe J.
    Kelliher, Jessica
    Salter, Alexander I.
    Hudecek, Michael
    Comstock, Melissa L.
    Rajan, Anusha
    Patel, Bharvin K. R.
    Voutsinas, Jenna M.
    Wu, Qian
    Liu, Lingfeng
    Cowan, Andrew J.
    Wood, Brent L.
    Green, Damian J.
    Riddell, Stanley R.
    BLOOD, 2019, 134 (19) : 1585 - 1597
  • [36] Current Status of Chimeric Antigen Receptor T-Cell Therapy in Multiple Myeloma
    Jindal, Vishal
    Khoury, John
    Gupta, Ruby
    Jaiyesimi, Ishmael
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2020, 43 (05): : 371 - 377
  • [37] Chimeric Antigen Receptor T-Cell Therapeutics for Multiple Myeloma Moving Into the Spotlight
    Wang, Bo
    Rajeeve, Sridevi
    Madduri, Deepu
    CANCER JOURNAL, 2021, 27 (03): : 205 - 212
  • [38] A compound chimeric antigen receptor strategy for targeting multiple myeloma
    Chen, K. H.
    Wada, M.
    Pinz, K. G.
    Liu, H.
    Shuai, X.
    Chen, X.
    Yan, L. E.
    Petrov, J. C.
    Salman, H.
    Senzel, L.
    Leung, E. L. H.
    Jiang, X.
    Ma, Y.
    LEUKEMIA, 2018, 32 (02) : 402 - 412
  • [39] The prospects and promise of chimeric antigen receptor immunotherapy in multiple myeloma
    Rotolo, Antonia
    Caputo, Valentina
    Karadimitris, Anastasios
    BRITISH JOURNAL OF HAEMATOLOGY, 2016, 173 (03) : 350 - 364
  • [40] A compound chimeric antigen receptor strategy for targeting multiple myeloma
    K H Chen
    M Wada
    K G Pinz
    H Liu
    X Shuai
    X Chen
    L E Yan
    J C Petrov
    H Salman
    L Senzel
    E L H Leung
    X Jiang
    Y Ma
    Leukemia, 2018, 32 : 402 - 412
12345